Stock Track | Quidel Stock Soars 7.18% Pre-Market as US-China Tariff Deal Boosts Life Sciences Sector

Stock Track
May 12, 2025

Quidel Corporation (QDEL) stock is soaring 7.18% in pre-market trading on Monday, as investors react positively to a new trade agreement between the United States and China. The deal, which aims to slash tariffs, has sparked a broad rally across the life sciences sector.

The US-China trade agreement is expected to significantly benefit companies in the life sciences industry, potentially reducing costs and improving access to the Chinese market. Quidel, a prominent player in the diagnostic healthcare products market, is among several companies in the sector seeing substantial gains.

Other major players in the life sciences industry are also experiencing notable increases in their stock prices. Bio-Techne is up 6.1%, Bio-Rad Laboratories has risen 5.9%, and Thermo Fisher Scientific has gained 4.7%. This sector-wide rally underscores the potential impact of the trade deal on companies involved in medical research, diagnostics, and healthcare technology.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10